Document is current
Any future updates will be listed below
-
Authors
Valles, Thomas E.
Shamas, Mohamad
Hawkins, Hope
Matthews, Cole
Ngo, Doan
Peltekian, Hrag
Artin, Hewa
Distler, Margaret G.
DeYoung, Dustin Z.
Einstein, Evan H. https://orcid.org/0000-0001-6489-4128
Ginder, Nathaniel D. https://orcid.org/0000-0003-1854-2337
Koek, Ralph J.
Krantz, David E.
Leuchter, Michael K.
Oughli, Hanadi A.
Slan, Aaron R. https://orcid.org/0009-0000-8657-1530
Strouse, Thomas B.
Tadayonnejad, Reza https://orcid.org/0000-0002-4665-6721
Wilke, Scott A.
Young, Alexander S. https://orcid.org/0000-0002-9367-9213
Corlier, Juliana
Leuchter, Andrew F.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K01MH123887)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH135293)
- License Information
-
More Information
Article History
Received: 29 August 2025
Revised: 17 November 2025
Accepted: 10 December 2025
First Online: 7 January 2026
Competing interests
: Thomas E. Valles, Mohamad Shamas, Hope Hawkins, Cole Matthews, Doan Ngo, Hrag Peltekian, Hewa Artin, Margaret G. Distler, Dustin Z. DeYoung, Evan H. Einstein, Nathaniel D. Ginder, Ralph J. Koek, David E. Krantz, Hanadi A. Oughli, Aaron R. Slan, Thomas B. Strouse, Reza Tadayonnejad, Scott A. Wilke, Alexander S. Young, and Juliana Corlier report no financial relationships with commercial interests. Juliana Corlier discloses that she has received research support from the NIH. Michael K. Leuchter discloses that with the past 36 months, he has received funding from the National Institute on Aging (NIA) and Alzheimer’s Association to attend the Institute on Methods and Protocols for Advancement of Clinical Trials in Alzheimer’s Disease and Related Dementias (IMPACT-AD). Andrew F. Leuchter discloses that he has received research support from the NIH, AE Research Foundation, MagVenture, BrainsWay, Abbott, Kernel, Neurolief, and Neuroptics, Inc. He has served as a consultant to Oruka Therapeutics, GrayMatters Health, Elevance Health, and Anthem Blue Cross.
